The Cannabis Pharmaceuticals Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for cannabis pharmaceuticals has seen exponential growth recently. The market size is projected to increase from $6.03 billion in 2024 to $9.45 billion in 2025, growing at a CAGR of 56.66%.
The Cannabis Pharmaceuticals Global Market Report 2025 predicts the market will reach a size of $56.37 billion in 2029, with a CAGR of 56.29%.
Download Your Free Sample of the 2025 Cannabis Pharmaceuticals Market Report and Uncover Key Trends Now!The key drivers in the cannabis pharmaceuticals market are:
•Increasing regulatory approvals for cannabis pharmaceuticals
•Growing awareness of medical benefits provided by cannabis
•Expanding applications of cannabis in pain and neurological disorder management
•Continued innovations in cannabis drug delivery systems
The cannabis pharmaceuticals market covered in this report is segmented –
1) By Product Type: Cannabinoid-Based Pharmaceuticals, Cannabis Extracts, Synthetic Cannabinoids
2) By Formulation Type: Capsules And Tablets, Oils And Tinctures, Topical Solutions
3) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management
4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
5) By End-User: Hospitals And Clinics, Rehabilitation Centers, Research Organizations
Subsegments:
1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations
2) By Cannabis Extracts: Full-Spectrum Cannabis Extracts, Broad-Spectrum Cannabis Extracts, Isolate Cannabis Extracts (CBD Isolate)
3) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists, Designer Synthetic Cannabinoids
The key trends in the cannabis pharmaceuticals market are:
•The adoption of advanced cannabinoid extraction technologies is a notable emerging trend.
•The development of targeted drug delivery systems is shaping the cannabis pharmaceuticals market.
•The shift towards synthetic cannabinoid formulations is becoming more prevalent.
•The use of artificial intelligence for drug discovery and improved clinical trial methodologies is an emerging trend.
Major players in the cannabis pharmaceuticals market are:
• Curaleaf Holdings Inc.
• Aphria Inc.
• Green Thumb Industries Inc.
• Trulieve Cannabis Corp.
• Tilray Inc.
• Cresco Labs Inc.
• Columbia Care Inc.
• Acreage Holdings Inc.
• Canopy Growth Corporation
• Aurora Cannabis Inc.
• MedMen Enterprises Inc.
• OrganiGram Holdings Inc.
• Cronos Group
• Enveric Biosciences Inc.
• Auxly Cannabis Group Inc.
• Valens Company Inc.
• Charlotte's Web Holdings Inc.
• Medical Marijuana Inc.
• Aleafia Health Inc.
• Supreme Cannabis Company Inc.
• Avicanna Inc.
• Emerald Health Therapeutics Inc.
North America was the largest region in the cannabis pharmaceuticals market in 2024